Provided by Tiger Fintech (Singapore) Pte. Ltd.

ReShape Lifesciences, Inc.

0.3946
+0.01142.97%
Post-market: 0.3925-0.0021-0.53%19:59 EDT
Volume:10.03M
Turnover:4.08M
Market Cap:4.45M
PE:-0.03
High:0.4360
Open:0.3943
Low:0.3700
Close:0.3832
Loading ...
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Major Issues Report

8-K - Current report
Feb 03, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 22, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 18, 2020

Major Issues Report

8-K - Current report
Dec 15, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2020

Major Issues Report

8-K - Current report
Oct 23, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 25, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 22, 2020

Major Issues Report

8-K - Current report